ABOUT GATEWAY FOR CANCER RESEARCHSM

We fund clinical trials for all types of cancers and prioritize only the most cutting-edge research that can help patients today. Gateway invests in next generation of potential breakthroughs in patient-centric cancer research in order to drive transformational advances in cancer treatment.

How Gateway is Unique:

  • Patients have a voice.
  • Helping cancer patients feel better and live longer.
  • Gateway invests in breakthrough research that is both targeted and precise.
  • 99 cents of every dollar Gateway receives goes directly to fund Phase I and Phase II cancer clinical trials.

CANCER RESEARCH: FUNDED CLINICAL TRIALS

Gateway focuses exclusively on patient-centered cancer research that improves treatment outcomes and restores the cancer patients’ quality of life. 

Since its inception over 24 years ago, Gateway has funded over 120 innovative cancer research clinical trials. New trials are continuously added in a rolling grant application process.

FUND ONE DAY

Gateway only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen. Phase I and II clinical trials are severely underfunded, yet have the greatest patient impact in conquering cancer.

It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial. Will you help us fund another day of research? Fund one day, one week or more!

Fund One Day

CONNECT

In the News

Gateway for Cancer Research’s annual Cures Gala, one of Chicago’s premier social events, was treated to surprise performances by R&B Music Hall of Famers, The Chi-Lites and the Grammy Hall of Fame group, The Temptations. The performances helped boost donations to fund innovative cancer clinical trial research.

More In the News

Media

Margie Roman
Director of Marketing & Development
Margie.Roman@gatewaycr.org

More Media

Mission Partners